Letter to the editor from Schultes et al - Reply Journal Article
| Authors: | Sabbatini, P.; Odunsi, K. |
| Article Title: | Letter to the editor from Schultes et al - Reply |
| Keywords: | cancer survival; unclassified drug; clinical trial; drug safety; letter; in vitro study; monoclonal antibody; cancer regression; immune response; immunogenicity; ovary tumor; ca 125 antigen; antibody production; abagovomab; passive immunization; oregovomab |
| Journal Title: | Clinical Cancer Research |
| Volume: | 13 |
| Issue: | 13 |
| ISSN: | 1078-0432 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2007-07-01 |
| Start Page: | 4026 |
| Language: | English |
| DOI: | 10.1158/1078-0432.ccr-07-0718 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | --- - "Export Date: 17 November 2011" - "CODEN: CCREF" - "Source: Scopus" |
